278
Vol. 60, No. 2
Table 1. 13C-NMR Data for 1, 1a, 2, 2a, 3, 3a, and 4 in C5D5N
was treated with naringinase (Sigma Aldrich, EC 232-962-
4, 90.3mg) in AcOH/AcOK buffer (pH 4.3, 2mL) at room
temperature for 72h. The reaction mixture was subjected
to silica gel CC eluted with CHCl3–MeOH (19:1) to yield
1a (17.2mg) and a sugar fraction (10.0mg), which was then
analyzed by HPLC under the following conditions: column,
Capcell Pak NH2, UG80 (4.6mm i.d×250mm, 5μm, Shiseido,
Tokyo, Japan); solvent, MeCNH2O (85:15); flow rate, 1.0mL/
min; detection, OR. Identification of D-glucose present in the
sugar fraction was carried out by comparison of its retention
time and optical rotation with those of an authentic sample. tR
(min): 13.5 (D-glucose, positive optical rotation).
1
1a
2
2a
3
3a
4
1
2
82.5
37.5
67.8
43.2
139.7
131.5
71.7
41.8
48.7
42.5
23.9
40.9
43.1
55.1
40.2
71.8
57.7
13.8
14.4
36.1
15.3
75.3
32.1
36.7
28.4
22.7
23.0
101.3
75.4
78.6
72.3
78.2
63.5
78.0
43.8
67.9
43.0
140.6
131.4
72.2
41.8
49.8
43.2
24.3
41.2
43.1
55.3
40.3
71.8
57.8
13.8
13.5
36.1
15.3
75.3
32.2
36.8
28.5
22.8
23.0
82.7
37.5
67.8
43.7
139.6
124.8
31.9
33.3
50.4
42.8
23.8
40.9
42.4
54.9
37.2
71.5
58.3
13.7
14.7
36.1
15.6
76.4
28.9
42.3
69.7
29.7
30.5
101.2
75.4
78.6
72.4
78.2
63.6
78.2
43.5
68.1
44.0
140.3
124.5
32.2
33.2
51.2
42.3
24.2
41.1
42.4
55.1
37.2
71.5
58.3
13.6
14.2
36.1
15.6
76.3
28.9
42.4
69.7
29.7
30.5
81.1
37.5
67.7
39.6
43.0
29.0
32.3
36.6
54.9
41.4
23.7
41.1
42.5
54.8
37.2
71.5
58.4
13.8
8.2
77.3
44.0
67.9
39.6
43.0
29.1
32.5
36.4
55.8
42.0
24.7
41.4
42.6
55.0
37.3
71.5
58.4
13.8
7.6
37.5
30.2
75.0
39.0
140.9
121.9
32.2
31.9
50.5
37.0
21.1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
1′
2′
3′
4′
5′
6′
1″
2″
3″
4″
5″
6″
Compound 1a: Amorphous solid. [α]D25 −9.3 (c=0.07,
MeOH). HR-ESI-TOF-MS m/z: 473.3246 [M+Na]+ (Calcd for
C27H46NaO5: 473.3243). IR νmax (film) cm−1: 3293 (OH), 2955
40.4
42.7
54.9
37.0
71.6
58.1
13.4
19.4
36.0
15.6
76.3
28.9
42.3
69.7
29.7
30.5
100.4
77.8
79.6
71.8
78.3
62.7
102.0
72.6
72.8
74.2
69.5
18.7
1
(CH), 1097 (C–O). H-NMR (600MHz, C5D5N) δ: 5.97 (1H,
brd, J=4.5Hz, H-6), 4.87 (1H, ddd, J=7.5, 7.0, 3.5Hz, H-16),
4.22 (1H, m, H-22), 4.14 (1H, brd, J=6.5Hz, H-7), 4.01 (1H,
m, W1/2=26.9Hz, H-3), 3.85 (1H, dd, J=11.0, 4.5Hz, H-1), 2.64
(1H, m, H-20), 1.71 (1H, dd, J=11.5, 7.0Hz, H-17), 1.36 (3H,
s, Me-19), 1.33 (3H, s, Me-18), 1.23 (3H, d, J=7.0Hz, Me-21),
0.90 (3H×2, d, J=6.5Hz, Me-26, 27). 13C-NMR (150MHz,
C5D5N): see Table 1.
36.1
15.6
76.4
28.9
42.2
69.7
29.7
30.5
100.4
75.5
78.6
72.2
78.3
63.5
36.1
15.6
76.4
28.9
42.3
69.7
29.8
30.5
Preparation of 1b and 1c To a solution of 1a (4.0mg) in
CH2Cl2 (0.4mL), (R)-(−)-MTPA (21.3mg), EDC·HCl (13.8mg),
and 4-DMAP (3.8mg) were added, and the mixture was
stirred at room temperature for 48h. The reaction mixture was
poured into optimal H2O, which was extracted with EtOAc
(3mL×3). Evaporation of the solution followed by silica gel
CC eluted with hexane–acetone (4:1) gave 1b (8.4mg). Using
the same procedure, a mixture of 1a (4.0mg) and (S)-MTPA
(21.4mg) yielded 1b (7.7mg).
Compound 2: Amorphous solid. [α]D25 −39.3 (c=0.10,
MeOH). HR-ESI-TOF-MS m/z: 613.3987 [M+H]+ (Calcd for
C33H57O10: 613.3952). IR νmax (film) cm−1: 3224 (OH), 2940
1
(CH), 1158 and 1075 (C–O). H-NMR (500MHz, C5D5N) δ:
5.59 (1H, brd, J=5.5Hz, H-6), 5.00 (1H, d, J=7.5Hz, Glc-
1), 4.74 (1H, ddd, J=7.7, 7.0, 3.5Hz, H-16), 4.56 (1H, brd,
J=11.7Hz, Glc-6a), 4.35 (1H, dd, J=11.7, 4.2Hz, Glc-6b), 4.24
(1H, dd, J=8.8, 8.8Hz, Glc-3), 4.19 (1H, m, H-22), 4.15 (1H,
dd, J=8.8, 8.8Hz, Glc-4), 4.07 (1H, dd, J=8.8, 7.5Hz, Glc-2),
4.01 (1H, dd, J=11.6, 4.0Hz, H-1), 3.89 (1H, m, W1/2=20.8Hz,
H-3), 2.62 (1H, m, H-20), 1.62 (1H, dd, J=11.0, 7.0Hz, H-17),
MeOH–H2O (3:2), silica gel CC with CHCl3–MeOH (3:1), 1.43 (3H×2, s, Me-26, 27), 1.29 (3H, s, Me-19), 1.19 (3H, s,
and preparative HPLC using MeCN–H2O (10:23) to yield 4 Me-18), 1.14 (3H, d, J=7.0Hz, Me-21). 13C-NMR (125MHz,
(5.9mg).
Compound 1: Amorphous solid. [α]D25 −7.8 (c=0.10,
C5D5N): see Table 1.
Enzymatic Hydrolysis of 2 Compound 2 (1.7mg) was
MeOH). HR-ESI-TOF-MS m/z: 635.3756 [M+Na]+ (Calcd for treated with naringinase (20.4mg) in AcOH/AcOK buffer (pH
C33H56NaO10: 635.3771). IR νm1ax (film) cm−1: 3215 (OH), 2951 4.3, 1mL) at room temperature for 168h. The reaction mix-
(CH), 1170 and 1073 (C–O). H-NMR (500MHz, C5D5N) δ: ture was subjected to silica gel CC eluted with CHCl3–MeOH
5.89 (1H, brd, J=7.3Hz, H-6), 5.00 (1H, d, J=7.7Hz, Glc-1), (9:1) to yield 2a (0.7mg) and a sugar fraction (0.4mg). HPLC
4.81 (1H, m, H-16), 4.55 (1H, dd, J=11.4, 2.7Hz, Glc-6a), 4.34 analysis of the sugar fraction under the same conditions as in
(1H, dd, J=11.4, 5.8Hz, Glc-6b), 4.23 (1H, dd, J=8.5,8.5Hz, the case of 1 showed the presence of D-glucose tR (min): 13.7
Glc-3), 4.19 (1H, m, H-22), 4.13 (1H, dd, J=8.5, 8.5Hz, Glc-4), (D-glucose, positive optical rotation).
4.05 (1H, dd, J=8.5, 7.7Hz, Glc-2), 4.04 (1H, brd, J=8.0Hz,
Compound 2a: Amorphous solid. [α]D25 −14.9 (c=0.07,
H-7), 4.00 (1H, dd, J=11.4, 4.0Hz, H-1), 3.94 (1H, m, Glc-5), MeOH). HR-ESI-TOF-MS m/z: 473.3252 [M+Na]+ (Calcd for
3.89 (1H, m, W1/2=20.8Hz, H-3), 2.59 (1H, m, H-20), 1.69 (1H, C27H46NaO5: 473.3243). IR νma1x (film) cm−1: 3364 (OH), 2961
m, H-17), 1.26 (3H, s, Me-19), 1.24 (3H, s, Me-18), 1.17 (3H, d, and 2923 (CH), 1095 (C–O). H-NMR (600MHz, C5D5N) δ:
J=7.0Hz, Me-21), 0.87 (3H×2, d, J=6.6Hz, Me-26, Me-27). 5.65 (1H, brd, J=5.4Hz, H-6), 4.79 (1H, m, H-16), 4.21 (1H,
13C-NMR (125MHz, C5D5N): see Table 1.
Enzymatic Hydrolysis of Compound
m, H-22), 4.00 (1H, m, W1/2=23.5Hz, H-3), 3.85 (1H, dd,
1
1
(35.0mg) J=10.5, 6.0Hz, H-1), 2.66 (1H, m, H-20), 2.02 (1H, m, H-7a),